1 / 46

Cardiac Arrhythmias

Cardiac Arrhythmias. A Guide For Medical Students William Beaumont Hospital Department of Emergency Medicine. Evaluating Arrhythmias. Rate – Is it fast or slow? If slow, is there group to group beating? Rhythm – Is it regular, irregular or irregularly irregular?

Download Presentation

Cardiac Arrhythmias

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cardiac Arrhythmias A Guide For Medical Students William Beaumont Hospital Department of Emergency Medicine

  2. Evaluating Arrhythmias • Rate – Is it fast or slow? • If slow, is there group to group beating? • Rhythm – Is it regular, irregular or irregularly irregular? • P waves – Are they present? • QRS – Is it narrow or wide?

  3. Sinus Bradycardia • What is it? • What causes it? • When do you treat it? • How do you treat it?

  4. Sinus Bradycardia • Characteristics: • Sinus rhythm • Normal intervals • Rate less than 60 bpm • Etiology: • Normal variant • Beta blocker overdose • Digoxin overdose • Hypothermia • Hypothyroidism • Brady-tachy syndrome • SA node ischemia

  5. Sinus Bradycardia • Treatment: • Requires treatment only if there is evidence of hypoperfusion • Two treatment options: • Pacing: transvenous or transcutaneous • Atropine 0.5 mg IVP

  6. Sinus Tachycardia • Characteristics: • Sinus rhythm • Faster than 100 bpm • Etiology: • Usually a physiologic response to a stressor • Volume depletion / low stroke volume • Hypoxia • Systemic pathology: fever, anemia, hyperthyroidism • Drugs • Treatment: • Treat the underlying cause

  7. Atrial Arrhythmias Premature Atrial Contraction (PAC) Multifocal Atrial Tachycardia (MAT) Atrial Fibrillation (A-fib) Atrial flutter (A-flutter) Supraventricular Tachycardia (SVT) Pre-excitation Syndromes (WPW)

  8. Multifocal Atrial Tachycardia • Three distinct p waves in a narrow complex tachycardia • Causes: • Almost always associated with pulmonary disease (hypoxia) • Less often due to hypokalemia or hypomagnesemia • Treatment: • Treat the underlying disorder – usually hypoxia • Unlike the other atrial tachyarrhythmias, cardioversion is of no value in MAT

  9. MAT Rule of Threes 3different p waves, 3different pr intervals and 3 different r to r intervals

  10. Atrial Fibrillation: Causes • Cardiovascular – CAD, HTN, CHF, myopathy, myo-, endo- and pericarditis, infiltrative disease, valvular, congenital • Metabolic – thyroid, electrolytes • Pulmonary – pulmonary HTN, PE • Toxic – cocaine, ETOH (holiday heart), beta agonists • Sepsis • Idiopathic

  11. Atrial Fibrillation: EKGs • Regularity – irregularly irregular • Rate – atrial rate usually > 350 • Controlled – ventricular rate < 100 • RVR – ventricular rate > 100 • P wave – none discernable, may be flutter waves • QRS • Less that 0.12 seconds • If > 0.12 sec must rule out VT (which is usually more regular)

  12. Atrial Fibrillation with RVR • Ventricular rate > than 100-120 bpm • Patients usually symptomatic requiring rapid treatment • Unstable – cardioversion • Stable – control rate with calcium channel blockers, beta blockers or digitalis

  13. Atrial Fibrillation Treatment • Recognize the underlying cause • A rate under 120 in an asymptomatic patient generally requires no emergent treatment • Unstable patients with acute rapid a-fib should receive synchronized cardioversion with 50-100 J • Treatment otherwise depends on the duration

  14. Atrial Fibrillation Treatment • Less than 48 hours duration • Unstable – Cardiovert, synchronized if possible, with 50-100 J • May also cardiovert electively in symptomatic, stable patients • Pharmacologic cardioversion • Procainamide • Amiodarone • Ibutilide

  15. Atrial Fibrillation Treatment • Longer duration predisposes the patient to atrial clot formation and failure of conversion • Greater than 48 hours duration • Rate control with diltiazem, beta blockers or digitalis • Do not attempt cardioversion unless emergently indicated • Anticoagulation and arrangement for echo

  16. Atrial Flutter • Patients usually with cardiac or pulmonary disease • Conduction through the AV node may be at a 2,3, 4, or 5:1 rate • If you see a ventricular rate close to 150, consider atrial flutter • Frequently is a transient rhythm which may degenerate into atrial fibrillation or convert to sinus

  17. Treatment of Atrial Flutter • Unstable – immediate synchronized cardioversion • Stable • Vagal manuevers – if no carotid bruits • Adenosine – will not terminate the atrial tachycardia, but may allow flutter waves to become more apparent • Dig, beta blockers or calcium channel blockers for AV nodal blockade to slow the ventricular rate

  18. Supraventricular Tachycardia (SVT) • AV nodal reentrant tachycardia • Usually regular, narrow complex tachycardia without p waves • Treatment • Adenosine • Beta blockers • Calcium channel blockers • Digoxin

  19. SVT – HR around 150s Is it SVT, a-fib, a-flutter, sinus tach?

  20. Wolf-Parkinson-White Syndrome • Pre-excitation Syndrome • AV re-entrant tachycardia (accessory pathway) • Short PR interval, delta waves • Treatment: • Treat like SVT if the QRS is narrow • If the QRS is wide or if afib is present, use amiodarone or procainamide • Slow the atrial rate and increase conduction through the AV node • Avoid ABCD – adenosine, beta blockers, calcium channel blockers, digoxin if wide QRS

  21. Narrow complex WPW

  22. Wide complex WPW

  23. Atrioventricular Blocks First Degree Second Degree - Type I Second Degree - Type II Third Degree

  24. Second Degree AV Blocks • Group to group beating • Second degree blocks are partial blocks • Two types • Type I, Mobitz I or Wenckebach – transient • Type II, Mobitz II or Classic – often degenerates into 3rd degree heart block

  25. Second Degree: Mobitz Type I • Decremental conduction: grouped beats with progressively longer PR intervals until an impulse is not conducted (a p without a QRS) • Usually narrow QRS • May be associated with inferior MI • Treatment: • Generally requires no treatment • Atropine, temporary pacing if symptomatic

  26. Second Degree, Mobitz Type II • Conduction fails suddenly, no change in the PR interval • This is NOT a benign rhythm • Often progresses to a complete heart block • Associated with anteroseptal MI • May have wide QRS

  27. Second Degree, Type II: Treatment • No pharmacologic treatment • Atropine has no effect on the His-Purkinje system and may worsen the conduction ratio • Emergency treatment – transcutaneous or transvenous pacing

  28. Third Degree Block • Complete block – there is total AV Dissociation • None of the atrial impulses are conducted through to the ventricles • P and QRS are independent, P-P and R-R intervals constant • An escape rhythm will drive the ventricles • If the escape rhythm originates in the AV junction, the ventricular rate will be in the range of 40-60 with a narrow QRS • If the escape rhythm originates in the ventricles, the ventricular rate will be in the range of 20-40 with a wide QRS

  29. Third Degree Block: Treatment • Although patients may be asymptomatic, transcutaneous or transvenous pacing is warranted • Autonomic drugs such as atropine will have no effect on ventricular rate • Type I anti-arrhythmics should be avoided as they may suppress the escape rhythm

  30. Ventricular Arrhythmias Premature Ventricular Contraction (PVC) Ventricular tachycardia (VT) Ventricular fibrillation (V-fib)

  31. PVCs: Causes • Generally benign • May be a consequence of a pathology, especially if multifocal • More concerning causes including hypoxia, ischemia, MI, toxins/drugs, acidosis or alkalosis, hypokalemia

  32. Ventricular Tachycardia • Results from a dysrhythmia originating at or below the bundle of His • Has a wide QRS complex (>0.12 second) • May be monomorphic or polymorphic

  33. Monomorphic V-tach • Morphologically consistent QRS complexes • Most common form of V-tach • Seen primarily with cardiac ischemia • Also seen in cardiomyopathy, valvular disease, electrolyte imbalance, myocarditis

  34. Polymorphic V-tach • QRS complexes vary in structure and amplitude • Predominantly caused by CAD • Associated with more severe disease

  35. Torsades de Pointes • A specific form of polymorphic v-tach • Associated with prolonged QT • May be due to drugs (tricyclics), electrolyte imbalance (hypo K, Mg or Ca), or subarachnoid hemorrhage

  36. V-Tach: Treatment • Unstable: • Immediate unsynchronized cardioversion • 100J, 200J, 300J, 360 J • Stable: • Amiodorone 150 mg IVP or lidocaine 1 mg/kg • Prepare for elective synchronized cardioversion • Torsades de Pointes: magnesium sulfate 1-2g IV

  37. Ventricular Fibrillation • An irregularly irregular rhythm with no p waves or definite QRS complexes

  38. Treatment of V Fib • Defibrillate • Adult: 360/360/360 joules • Children: 2 J/kg • Epinephrine 1 mg IVP q 3-5 min (0.01 mg/kg) • Amiodarone • Lidocaine • Magnesium

  39. Other EKG Abnormalities Osborne Waves Brugada Syndrome

  40. Osborne Waves • Not a true arrhythmia, but an EKG abnormality suggestive of underlying pathology • Seen primarily in hypothermia, < 35.6 degrees • May also be seen in other conditions, such as hypercalcemia or brain injury • Also called J-waves, Camel backs, hathooks

  41. Osborne Waves – Hypothermia

  42. Osborne Waves – Hypercalcemia

  43. Brugada Syndrome Genetic disease – autosomal dominant Mutation in the gene that controls the Na channel Prevalence for Asians Characteristic ECG: ST segment elevation V1-V3 No signs of ischemia Short QT interval Most common cause of sudden death in young males with no underlying cardiac disease Cause of death – polymorphic V-tach or V-fib Treatment: AICD to abort lethal arhythmias

  44. Brugada Syndrome: Diagnostic Criteria • Type I is the only ECG criterion that is diagnostic of Brugada (see figure). • Definitive diagnosis – Type 1 ST-segment is observed in greater than one right precordial lead (V1 to V3) PLUS one of the following: • Documented V-fib • Polymorphic VT • Family history of sudden cardiac death at <45 yo • Inducibility of VT with electrical stimulation • Coved-type ECGs in family members • syncope • nocturnal agonal respiration.

  45. Brugada Syndrome

  46. The End Any Questions?

More Related